Primary Central Nervous System Lymphoma in North Carolina: Updates for 2022 - LIVE
Christopher Dittus, DO, MPH, from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for rare lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
- Explain the diagnosis of Primary Central Nervous System lymphoma (PCNSL)
- Describe the frontline treatment approach for mantle cell lymphoma.
- Describe new modalities for treating relapsed mantle cell lymphoma.
Please feel free to share the flyer and/or this webpage.
Taking the Course
To continue, log in and click the button Take Course.
If you do not see the button, please ensure that you are logged in. If you are logged in and still don't see the button, please contact us at email@example.com or (919) 455–1000.
Christopher Dittus, DO, MPH
Presenter Disclosure Information
Christopher Dittus, DO, MPH, receives consulting fees from Beigene and Genmab. These relationships have been mitigated through slide review by UNC CPD.
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Tech
- 1.00 AMA PRA Category 1 Credit™
- 1.00 AMA PRA Category 1 Credit™ - Non-physician
- 1.00 ASRT
- 1.00 CTR
- 1.00 NCPD/CNE
- 1.00 Participation